Literature DB >> 8331478

Survival and development of larval Onchocerca volvulus in diffusion chambers implanted in primate and rodent hosts.

D Abraham1, A M Lange, W Yutanawiboonchai, M Trpis, J W Dickerson, B Swenson, M L Eberhard.   

Abstract

Third-stage larvae (L3) of Onchocerca volvulus were implanted in diffusion chambers in chimpanzees, mangabey monkeys, rhesus monkeys, squirrel monkeys, and inbred strains of mice, jirds, and rats for 3-63 days. At different times during the experimental period, larvae were recovered and assessed for their viability and development. Survival and growth rates were equal regardless of whether the implanted larvae were fresh or cryopreserved. Survival and growth rates of the larvae did not differ among the primate and rodent hosts tested, with the exception of squirrel monkeys and rats, which were resistant to infection. Molting from L3 to fourth-stage larvae began on day 3 and continued through day 14 in the primates and rodents. The primate and rodent models developed in the present study will be useful for the study of the immunology and chemotherapy of onchocerciasis.

Entities:  

Mesh:

Year:  1993        PMID: 8331478

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  15 in total

1.  Protective immunity to the larval stages of onchocerca volvulus is dependent on Toll-like receptor 4.

Authors:  Laura A Kerepesi; Ofra Leon; Sarah Lustigman; David Abraham
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Infection of BALB/c mice with the filarial nematode Litomosoides sigmodontis: role of CD4+ T cells in controlling larval development.

Authors:  K M Al-Qaoud; A Taubert; H Zahner; B Fleischer; A Hoerauf
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  Ocular zoonotic onchocerca infection in a resident of Oregon.

Authors:  Mark L Eberhard; Annette C Sims; Henry S Bishop; Blaine A Mathison; Richard S Hoffman
Journal:  Am J Trop Med Hyg       Date:  2012-10-29       Impact factor: 2.345

4.  Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of Onchocerca volvulus Infection.

Authors:  Vitaliano A Cama; Circe McDonald; Alice Arcury-Quandt; Mark Eberhard; M Harley Jenks; Jared Smith; Sindew M Feleke; Francisca Abanyie; Lakwo Thomson; Ryan E Wiegand; Paul T Cantey
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

Review 5.  Onchocerca volvulus: The Road from Basic Biology to a Vaccine.

Authors:  Sara Lustigman; Benjamin L Makepeace; Thomas R Klei; Simon A Babayan; Peter Hotez; David Abraham; Maria Elena Bottazzi
Journal:  Trends Parasitol       Date:  2017-09-22

6.  Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans.

Authors:  James S McCarthy; Moira Wieseman; Joe Tropea; David Kaslow; David Abraham; Sara Lustigman; Rocky Tuan; Ronald H Guderian; Thomas B Nutman
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

7.  In vivo transfection of developmentally competent Brugia malayi infective larvae.

Authors:  Shulin Xu; Canhui Liu; George Tzertzinis; Elodie Ghedin; Christopher C Evans; Ray Kaplan; Thomas R Unnasch
Journal:  Int J Parasitol       Date:  2010-11-28       Impact factor: 3.981

8.  Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.

Authors:  D Abraham; O Leon; S Leon; S Lustigman
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

9.  Immunoprophylaxis of multi-antigen peptide (MAP) vaccine for human lymphatic filariasis.

Authors:  Christiana Immanuel; Aparnaa Ramanathan; Malathi Balasubramaniyan; Vishal Kishor Khatri; Nitin Purushottam Amdare; Donthamsetty Nageswara Rao; Maryada Venkata Rami Reddy; Kaliraj Perumal
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

10.  The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.

Authors:  Jessica A Hess; Bin Zhan; April R Torigian; John B Patton; Nikolai Petrovsky; Tingting Zhan; Maria Elena Bottazzi; Peter J Hotez; Thomas R Klei; Sara Lustigman; David Abraham
Journal:  PLoS Negl Trop Dis       Date:  2016-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.